1. Home
  2. AMCX vs EVO Comparison

AMCX vs EVO Comparison

Compare AMCX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

BUY

Current Price

$10.93

Market Cap

492.0M

ML Signal

BUY

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.56

Market Cap

568.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCX
EVO
Founded
1980
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.0M
568.6M
IPO Year
2011
2007

Fundamental Metrics

Financial Performance
Metric
AMCX
EVO
Price
$10.93
$1.56
Analyst Decision
Sell
Buy
Analyst Count
8
3
Target Price
★ $9.83
$4.17
AVG Volume (30 Days)
★ 553.5K
158.0K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 132.55
N/A
EPS
N/A
★ N/A
Revenue
★ $2,311,801,000.00
N/A
Revenue This Year
$5.07
N/A
Revenue Next Year
N/A
$20.51
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$6.47
$1.50
52 Week High
$12.93
$4.27

Technical Indicators

Market Signals
Indicator
AMCX
EVO
Relative Strength Index (RSI) 36.88 36.94
Support Level $9.23 $1.50
Resistance Level $11.13 $1.97
Average True Range (ATR) 0.40 0.07
MACD -0.14 0.01
Stochastic Oscillator 14.16 22.00

Price Performance

Historical Comparison
AMCX
EVO

About AMCX AMC Networks Inc.

AMC Global Media owns several linear TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network,reached 55 million pay TV households in the US at the end of 2025. The firm also had nearly 10.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: